arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

SI-BONE, Inc.

SIBN
$18.61 ▲ +0.47 (+2.59%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
10 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Bearish
auto_awesome

Analytical Summary

SI-BONE, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $799.5M
Dividend Yield
Revenue Growth 20.2%
Op. Margin -11.1%
ROIC -8.3%
FCF / Share $-0.21
Trailing P/E
Price / Book 4.6x
FCF Yield
Debt / Equity 0.20
info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$200.93M
↑ +20.2%
Net Income Profit after all expenses
$-18.90M
↑ +38.8%
Operating Margin Operating profit as % of sales
-11.1%
↑ +47.3% 14th
FCF / Share Free cash flow per share
$-0.21
↑ +61.7%
Long-Term Debt Long-term obligations
$35.57M
— +0.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
16
Returns
34
Financial Health
52
Cash Quality
39

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 37 quarters